Subclinical hyperthyroidism: to treat or not to treat?

Subclinical hyperthyroidism may be defined as the presence of free thyroxine and tri-iodothyronine levels within the reference range and a reduced serum thyroid stimulating hormone (TSH) level. In this review the prevalence of low TSH in the population and health consequences of subclinical hyperthy...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Postgraduate medical journal 2004-07, Vol.80 (945), p.394-398
Hauptverfasser:	Hoogendoorn, E H, den Heijer, M, van Dijk, A P J, Hermus, A R
Format:	Artikel
Sprache:	eng
Schlagworte:	Best Practice Biological and medical sciences BMD Bone Density bone mineral density Cardiac arrhythmia cardiac effects Dementia - etiology Endocrinopathies General aspects Health risk assessment Heart Diseases - etiology Humans hyperthyroidism Hyperthyroidism - complications Hyperthyroidism - therapy Medical sciences Mood Disorders - etiology Mortality Non tumoral diseases. Target tissue resistance. Benign neoplasms osteoporosis Pituitary gland Practice Guidelines as Topic Quality of Life subclinical hyperthyroidism Thyroid cancer thyroid stimulating hormone Thyroid. Thyroid axis (diseases) TSH
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Subclinical hyperthyroidism may be defined as the presence of free thyroxine and tri-iodothyronine levels within the reference range and a reduced serum thyroid stimulating hormone (TSH) level. In this review the prevalence of low TSH in the population and health consequences of subclinical hyperthyroidism, for example, effects on heart and bone mass, are discussed. Guidelines for treatment are given, based on expert opinion.
ISSN:	0032-5473 1469-0756
DOI:	10.1136/pgmj.2003.017095